1. Home
  2. JRSH vs NXTC Comparison

JRSH vs NXTC Comparison

Compare JRSH & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$3.32

Market Cap

41.9M

ML Signal

HOLD

Logo NextCure Inc.

NXTC

NextCure Inc.

N/A

Current Price

$10.25

Market Cap

39.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JRSH
NXTC
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
39.1M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
JRSH
NXTC
Price
$3.32
$10.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$4.00
$23.00
AVG Volume (30 Days)
134.6K
51.0K
Earning Date
02-09-2026
05-04-2026
Dividend Yield
5.68%
N/A
EPS Growth
56.25
N/A
EPS
0.15
N/A
Revenue
$145,812,006.00
$22,378,000.00
Revenue This Year
$11.64
N/A
Revenue Next Year
$10.06
N/A
P/E Ratio
$22.00
N/A
Revenue Growth
24.43
N/A
52 Week Low
$2.85
$0.42
52 Week High
$3.60
$15.74

Technical Indicators

Market Signals
Indicator
JRSH
NXTC
Relative Strength Index (RSI) 48.87 49.68
Support Level $3.20 $8.45
Resistance Level $3.47 $10.81
Average True Range (ATR) 0.13 0.78
MACD -0.03 0.07
Stochastic Oscillator 23.68 68.70

Price Performance

Historical Comparison
JRSH
NXTC

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: